Table 3.
Predictors of the Presence of Fatty Liver in Patients with NAFLD
| Variable | Univariate | Multivariate | |||
|---|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | ||
| Age, yr | 0.920 (0.882–0.960) | <0.001 | 0.972 (0.907–1.041) | 0.415 | |
| Hypertension | 0.230 (0.076–0.694) | 0.009 | 0.562 (0.064–4.943) | 0.603 | |
| Liver cirrhosis | 0.109 (0.031–0.390) | 0.001 | 0.877 (0.093–8.270) | 0.909 | |
| Dyslipidemia | 0.429 (0.114–1.612) | 0.210 | - | - | |
| Total bilirubin, mg/dL | 0.537 (0.164–1.753) | 0.303 | - | - | |
| Serum albumin, g/dL | 33.588 (4.027–280.164) | 0.001 | 9.477 (0.293–306.421) | 0.205 | |
| Platelet count, ×109/L | 1.027 (1.013–1.040) | <0.001 | 1.012 (0.997–1.028) | 0.116 | |
| Hepatic steatosis index | 1.211 (1.067–1.375) | 0.003 | 1.161 (0.958–1.407) | 0.128 | |
NAFLD, nonalcoholic fatty liver disease; OR, odds ratio; CI, confidence interval.